Does CETUXIMAB Cause Myelosuppression? 493 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 493 reports of Myelosuppression have been filed in association with CETUXIMAB (ERBITUX). This represents 3.4% of all adverse event reports for CETUXIMAB.
493
Reports of Myelosuppression with CETUXIMAB
3.4%
of all CETUXIMAB reports
4
Deaths
317
Hospitalizations
How Dangerous Is Myelosuppression From CETUXIMAB?
Of the 493 reports, 4 (0.8%) resulted in death, 317 (64.3%) required hospitalization, and 36 (7.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 493 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which CETUXIMAB Alternatives Have Lower Myelosuppression Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL